|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 First Street, SE, Suite 3 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 4/20/2015 11:30:21 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
Medicare-Medicaid dual eligible coverage and demonstration
Draft Hospital Improvement for Payment (HIP) Act
Medicare Payment Advisory Commission draft recommendations on per-beneficiary payment for primary care services
Medicaid and CHIP Payment and Access Commission draft report to Congress on the adequacy of pediatric provider networks in qualified health plans.
Telehealth provisions of the discussion draft 21st Century Cures legislation
HHS study on the comparability of CHIP coverage and benefits with those of marketplace health plans
H.R. 2 - Medicare Access and CHIP Reauthorization Act
H.R. 546/S. 298 - Advancing Care for Exceptional Kids (ACE Kids) Act
H.R. 700 - Stabilize Medicaid and CHIP Coverage Act
H.R. 818/S. 861 - Preventing and Reducing Improper Medicare and Medicaid Expenditures (PRIME) Act
H.R. 919 - CHIP Extension and Improvement Act
H.R. 1021 - Protecting Integrity of Medicare Act (PIMA)
H.R. 1190/S. 141 - Protecting Seniors Access to Medicare Act
H.R. 1470 - SGR Repeal and Medicare Provider Payment Modernization Act
S. 257/H.R. 1611 - Protecting Access to Rural Therapy Services Act
S. 578/H.R. 1342 - Home Health Care Planning Improvement Act
S. 737 - Ensuring Access to Primary Care for Women & Children Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Section 2706 of the ACA regarding provider non-discrimination
Policies affecting nurse practitioner education and workforce
Definition of essential health benefits
Health information technology and electronic health records
Mental health services and violence prevention
H.R. 30 - Save American Workers Act
H.R. 248/S. 305 - American Job Protection Act
H.R. 270 - Flexibility in Health IT Reporting (Flex-IT) Act
H.R. 596 - To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010
H.R. 609/S. 287 - Safe Food Act
H.R. 931 - Helping Effective Antibiotics Last (HEAL) Act
H.R. 932/S. 497 - Healthy Families Act
H.R. 933/S. 486 - Head Start on Vaccinations Act
H.R 1189/S. 620 - Preserving Employee Wellness Programs Act
H.R. 1209/S. 628 - Improving Access to Maternity Care Act
H.R. 1372 - Home Visiting Extension Act
H.R. 1462/S. 799 - Protecting Our Infants Act
H.R 1517 - Stop Selling and Marketing to Our Kids E-Cigarettes (SMOKE) Act
H.R. 1552 - Preservation of Antibiotics for Medical Treatment Act
S. 30 - Forty Hours Is Full Time Act
S. 142/H.R. 1375 - Child Nicotine Poisoning Prevention Act
S. 185 - Promise for Antibiotics and Therapeutics for Health (PATH) Act
S. 203 - American Liberty Restoration Act
S. 339 - ObamaCare Repeal Act
S. 522 - Protecting & Retaining Our Children's Health Insurance Program (PRO-CHIP) Act
S. 621 - Prevention of Antibiotic Resistance Act
S. 673 - Winding Down Obamacare Act
S. 674 - 21st Century Womens Health Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs in fiscal years 2015 and 2016
Federal funding for Nurse Managed Health Clinics
FY 2016 appropriations for antimicrobial research programs
FY 2016 appropriations for the Childrens Hospitals Graduate Medical Education Program
FY 2016 appropriations for the FDA Pediatric Device Consortia Grant Program
Impact of sequestration on the Health Resources and Services Administration (HRSA) and other discretionary Department of Health and Human Services spending
H.R. 240 - Department of Homeland Security Appropriations Act, 2015
H.R. 531 - Accelerating Biomedical Research Act
H. Con. Res. 27 - Establishing the budget for the United States Government for fiscal year 2016
S. Con. Res. 11 - Setting forth the congressional budget for the United States Government for fiscal year 2016
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
Legislation and policies related to:
S. 697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act
S. 725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Legislation and policies relating to:
H.R. 471 - Ensuring Patient Access and Effective Drug Enforcement Act
H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Legislation and policies relating to:
Revision of the Veterans Health Administration nursing handbook regarding full practice authority for advanced practice nurses
H.R. 1247 - Improving Veterans Access to Quality Healthcare Act
S. 297 - Frontlines to Lifelines Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |